- Home
- GLPG vs MLKN Comparison
GLPG vs MLKN Comparison
Compare GLPG & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- MLKN
- Stock Information
- Founded
- GLPG 1999
- MLKN 1905
- Country
- GLPG Belgium
- MLKN United States
- Employees
- GLPG N/A
- MLKN N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- MLKN Office Equipment/Supplies/Services
- Sector
- GLPG Health Care
- MLKN Consumer Discretionary
- Exchange
- GLPG Nasdaq
- MLKN Nasdaq
- Market Cap
- GLPG 1.8B
- MLKN 1.5B
- IPO Year
- GLPG 2005
- MLKN N/A
- Fundamental
- Price
- GLPG $26.74
- MLKN $22.24
- Analyst Decision
- GLPG Sell
- MLKN
- Analyst Count
- GLPG 5
- MLKN 0
- Target Price
- GLPG $26.75
- MLKN N/A
- AVG Volume (30 Days)
- GLPG 355.9K
- MLKN 454.7K
- Earning Date
- GLPG 02-12-2025
- MLKN 03-26-2025
- Dividend Yield
- GLPG N/A
- MLKN 3.37%
- EPS Growth
- GLPG N/A
- MLKN 36.08
- EPS
- GLPG 1.16
- MLKN 0.91
- Revenue
- GLPG $285,380,474.00
- MLKN $3,593,100,000.00
- Revenue This Year
- GLPG $2.78
- MLKN $4.29
- Revenue Next Year
- GLPG $1.62
- MLKN $4.62
- P/E Ratio
- GLPG $23.02
- MLKN $24.55
- Revenue Growth
- GLPG 14.99
- MLKN N/A
- 52 Week Low
- GLPG $22.36
- MLKN $20.89
- 52 Week High
- GLPG $37.22
- MLKN $31.73
- Technical
- Relative Strength Index (RSI)
- GLPG 71.20
- MLKN 47.66
- Support Level
- GLPG $26.49
- MLKN $22.25
- Resistance Level
- GLPG $27.48
- MLKN $22.98
- Average True Range (ATR)
- GLPG 0.66
- MLKN 0.58
- MACD
- GLPG 0.54
- MLKN 0.08
- Stochastic Oscillator
- GLPG 85.55
- MLKN 58.88
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract , International Contract & Specialty International & Specialty and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.